Microviable Therapeutics

Microviable obtained SME rating from EMA

2023-01-27T11:02:09+01:0027 de January de 2023|

The European Medicines Agency (EMA) granted the qualification of “Small and Medium-Sized Enterprises” (SME) to Microviable Therapeutics. The European Medicines Agency (EMA) provides incentives and support for micro, small and medium-sized enterprises (SMEs) that are [...]

Meet our research intern Evelyn Villegas

2022-12-22T10:44:04+01:0022 de December de 2022|

Microviable wants to introduce you our research intern Evelyn Villegas, who has completed Higher Level Professional Training practices in Multiplatform Application Development in the bioinformatics area. Evelyn has also a degree from Law school and [...]

Microviable will be attending Bio-Europe 2022

2022-10-11T14:44:35+02:0011 de October de 2022|

Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending BIO-Europe event in Leipzig, Germany, from October 24th to 26th. BIO-Europe® is the preeminent partnering conference for the [...]

Microviable welcomes Pilar Manrique, PhD on board

2022-09-28T11:08:38+02:0028 de September de 2022|

Welcome Pilar Manrique, PhD on board. Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018). Pilar has worked over ten years studying the [...]

Go to Top